GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo offers hope for advanced stomach cancer patients
Disease control Recruiting nowThis study tests two experimental drugs, AK109 and AK104, with or without chemotherapy, in people with advanced stomach or gastroesophageal junction cancer that has not responded to first-line treatment. The goal is to see if the combination can shrink tumors or slow disease prog…
Matched conditions: GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 26, 2026 09:21 UTC
-
New drug cocktail targets stomach cancer protein to extend lives
Disease control Recruiting nowThis study tests whether adding the drug Zolbetuximab to standard chemotherapy can help people with a specific type of advanced stomach or gastroesophageal cancer live longer. It is for patients whose tumors have a protein called CLDN18.2 and who have already tried one prior trea…
Matched conditions: GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 19, 2026 11:46 UTC